Physicians’ perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome
- 898 Downloads
To assess the practice patterns of pediatric rheumatology and infectious diseases subspecialists in the diagnosis and treatment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. An online survey assessing diagnostic and treatment approaches was sent to 424 members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and 980 members of the Pediatric Infectious Disease Society (PIDS). 277 physicians (123 from CARRA and 154 from PIDS representing 21% of the total membership) completed the survey. To diagnose PFAPA, most respondents agreed that patients must have the following features of the diagnostic criteria: stereotypical fever episodes (95%), asymptomatic intervals between episodes (93%), and normal growth and development (81%). However, 71% of the respondents did not require age of onset <5 years, 33% did not require regular intervals between episodes, and 79% did not require the concomitant signs of aphthous stomatitis, adenitis, or pharyngitis during episodes as long as episodes were regular. Over half (58%) considered episode resolution with steroids to be diagnostic of PFAPA. Corticosteroids, antipyretics, tonsillectomy, and cimetidine were the most commonly prescribed treatments, while steroids and tonsillectomy were most effective. Subspecialists in pediatric rheumatology and infectious diseases showed limited adherence to the complete published criteria for diagnosing PFAPA suggesting heterogeneity in the characteristics of patients diagnosed with the disorder. These findings emphasize the need to develop consensus diagnostic and treatment guidelines in well-characterized patient populations.
KeywordsAutoinflammatory syndrome Periodic fever Physician practice patterns PFAPA
We thank the members of CARRA and PIDS who participated in this survey and Sheffa Ariens (CARRA) and Christy Phillips (PIDS) for their help in distributing the survey. We are also grateful to Drs. Robert Sundel, Larry Zemel, Deborah Rothman, Lori Tucker, Debby McCurdy, Kelly Brown, and Annabelle de St. Maurice for their review of the survey. Dr. Tucker has received funding from Novartis to support research activities. No other conflicts of interest. CARRA is supported by Grants from National Institute of Arthritis and Musculoskeletal and Skin Diseases (RC2AR058934), Friends of CARRA, and the Arthritis Foundation, as well as by the Duke Clinical Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases or the National Institutes of Health. Support for REDCap provided by Vanderbilt Institute for Clinical and Translational Research Grant support (UL1 TR000445 from NCATS/NIH). Kalpana Manthiram was supported by the Childhood Infection Research Program (1T32AI095202-01) and Conducting Child Health Care Research in Vulnerable Populations (1T32HD060554-05) training Grants from Vanderbilt University School of Medicine.
Compliance with ethical standards
Conflict of interest
Dr. Goldsmith is a member of the Novartis Advisory Speakers Board. Authors report no other conflicts of interest.
- 7.Stojanov S, Lapidus S, Chitkara P, Feder H, Salazar JC, Fleisher TA et al (2011) Periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci 108:7148–7153CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome) (2010). Acta Paediatr 99: 178–184Google Scholar
- 14.Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358–360Google Scholar